# Quadrise keeps key trial programmes moving as partners stay engaged, Shore Capital

- Link: https://www.directorstalkinterviews.com/quadrise-keeps-key-trial-programmes-moving-as-partners-stay-engaged-shore-capital/4121246711
- Published: 2026-03-26T13:29:43+00:00
- Author: Anthony Fox

**[Quadrise plc](https://www.directorstalkinterviews.com/company/quadrise-plc/qed.l)**(
LON:QED) remains focused on turning long-running development work into commercial
progress, and Shore Capital’s latest research note suggests the company is still
moving in the right direction. The note, written by research analyst Tom Fraine,
CFA, said Quadrise reported a cash balance of £4.0 million at 31 December 2025 and
a first half loss after tax of £2.0 million, which was in line with Shore Capital’s
expectations.

For many readers, the most important takeaway from the latest research note from
Shore Capital is the continued commitment from Quadrise’s major trial partners. 
Fraine wrote, “All three parties remain committed to progressing the trial programme.”
That comment referred to Quadrise, MSC and Cargill as work continues to finalise
the trilateral and bilateral agreements needed for vessel trials.

That matters because these trials are central to the wider investment case. According
to Shore Capital, the planned operational trial on board an MSC vessel is expected
to begin with an initial Proof of Concept period using MSAR and then bioMSAR for
performance baseline tests. After that, the programme is set to move into 4,000 
hours of operation, roughly six to eight months, on bioMSAR. If successful, that
process is intended to support a Letter of No Objection from engine manufacturer
Wärtsilä.

The note also highlighted practical progress behind the scenes with Cargill. Shore
Capital said work has included obtaining International [Sustainability](https://www.directorstalkinterviews.com/sustainability-green-stocks-news)&
Carbon Certification for bioMSAR, resolving VAT and customs technicalities, setting
up a Quadrise Belgium branch, making trial permit applications and preparing trial
equipment. Once the relevant agreements are signed, equipment is due to be installed
and commissioned at the MAC² terminal in Antwerp.

Outside marine fuels, Quadrise appears to be keeping several other opportunities
active. In Morocco, Shore Capital said OCP remains committed to progressing MSAR
trials, with a signature expected soon ahead of the start of the trial. In Central
America, the permitting process for Quadrise’s fuels is underway in Panama following
successful testing at Sparkle Power’s El Giral plant in July 2025, while discussions
are also progressing with other regional operations. In Utah, Valkor’s 500 barrel
per day oil sands pilot plant is expected to become operational in the fourth quarter
of 2026. Shore Capital added that Valkor will make staged licence payments totalling
US$1.0 million through to June 2026, along with additional payments for equipment
and service charges.

There is also a broader product development angle that could become increasingly
relevant. The Shore Capital note said Quadrise has been progressing work with partners
on solvolysis, fast pyrolysis and hydrothermal liquefaction, among other pathways,
to develop scalable waste-based biofuel feedstocks that align with emerging regulatory
and sustainability requirements. In simple terms, the company is not relying on 
one single route, which may help it stay flexible as market demands and rules evolve.

Tom Fraine also underlined the scale of the opportunity if the company can convert
trials into meaningful commercial adoption. He wrote, “We believe Quadrise’s opportunity
with MSC and Cargill alone could generate substantial high-margin annual revenues
if only a small percentage of MSC’s overall fuel demand was switched to MSAR or 
bioMSAR.” He added that MSC currently consumes close to 10 million tonnes of fuel
oil each year, and Shore Capital believes Quadrise could charge about US$50 per 
tonne for the use of its technology.

## Highlights

 * Cash balance of £4.0 million at 31 December 2025.
 * First half loss after tax of £2.0 million, in line with Shore Capital’s expectations.
 * MSC, Cargill and Quadrise continue to work on vessel trial agreements.
 * OCP remains committed to progressing MSAR trials in Morocco.
 * Panama permitting is underway after successful Sparkle Power testing in July 
   2025.
 * Valkor’s Utah pilot plant is expected to become operational in Q4 2026.

## Final Thoughts

The latest research note from Shore Capital paints a constructive picture of Quadrise,
but it is still a story built around execution. The agreements need to be completed,
the trials need to run well, and the company still has to prove that technical progress
can become repeatable commercial revenue. Even so, the continued engagement of MSC,
Cargill and OCP, alongside activity in Panama and Utah, suggests that Quadrise is
still advancing across several fronts at once. For investors following the company,
the next phase looks likely to be defined by whether these trial programmes can 
move from preparation into delivery.

Share on:
